celiprolol has been researched along with Metabolic Acidosis in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, JA | 1 |
| Magistro, AM | 1 |
| Smith, RD | 1 |
| Pruss, TP | 1 |
| Wolf, PS | 1 |
1 other study available for celiprolol and Metabolic Acidosis
| Article | Year |
|---|---|
Celiprolol, a compound which attenuates myocardial acidosis and improves regional segmental function following ischemia in dogs: a comparison with propranolol.
Topics: Acidosis; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Body Temperature; Cardiomyopathies; | 1989 |